Metropolitan Life Insurance CO Asensus Surgical, Inc. Transaction History

Metropolitan Life Insurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.53 - $1.19 $15,273 - $34,292	-28,817 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$1.03 - $2.31 $29,681 - $66,567	28,817 New	28,817 $31,000
Q4 2021 Mar 30, 2023	SELL	$1.03 - $2.31 $15,968 - $35,811	-15,503 Reduced 34.98%	28,817 $31,000
Q4 2021 Feb 15, 2022	SELL	$1.03 - $2.31 $15,968 - $35,811	-15,503 Reduced 34.98%	28,817 $32,000
Q3 2021 Jun 21, 2023	BUY	$1.74 - $2.93 $77,116 - $129,857	44,320 New	44,320 $81,000
Q3 2021 Mar 30, 2023	SELL	$1.74 - $2.93 $41,763 - $70,325	-24,002 Reduced 35.13%	44,320 $81,000
Q3 2021 Nov 15, 2021	SELL	$1.74 - $2.93 $41,763 - $70,325	-24,002 Reduced 35.13%	44,320 $82,000
Q2 2021 Jun 21, 2023	BUY	$1.52 - $3.62 $103,849 - $247,325	68,322 New	68,322 $216,000
Q2 2021 Mar 30, 2023	BUY	$1.52 - $3.62 $103,849 - $247,325	68,322 New	68,322 $216,000
Q2 2021 Aug 16, 2021	BUY	$1.52 - $3.62 $103,849 - $247,325	68,322 New	68,322 $217,000

40.1M

12.4K

Ticker ASXC
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 236,719,008
Market Cap $82.9M
Description
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.